Impax Asset Management Group plc increased its position in Centene Corporation (NYSE:CNC – Free Report) by 466.4% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 230,086 shares of the company’s stock after purchasing an additional 189,462 shares during the period. Impax Asset Management Group plc’s holdings in Centene were worth $14,293,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of CNC. BlackRock Inc. acquired a new position in Centene during the second quarter worth $2,660,422,000. Wellington Management Group LLP lifted its stake in shares of Centene by 423.0% in the second quarter. Wellington Management Group LLP now owns 13,301,215 shares of the company’s stock valued at $853,805,000 after buying an additional 10,757,914 shares in the last quarter. Bank of America Corp DE acquired a new position in shares of Centene during the second quarter valued at about $285,713,000. Deutsche Bank AG bought a new stake in shares of Centene during the second quarter worth about $257,279,000. Finally, Legal & General Group Plc bought a new stake in shares of Centene during the second quarter worth about $244,463,000. Institutional investors and hedge funds own 93.63% of the company’s stock.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on the stock. Weiss Ratings upgraded shares of Centene from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, October 28th. Jefferies Financial Group reiterated a “hold” rating and set a $69.00 price target on shares of Centene in a research note on Thursday, October 29th. Sanford C. Bernstein reissued an “outperform” rating and set a $90.00 price objective on shares of Centene in a report on Tuesday. Cantor Fitzgerald increased their price objective on Centene from $75.00 to $79.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 28th. Finally, JPMorgan Chase & Co. set a $90.00 target price on Centene in a report on Tuesday. Nine research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $75.10.
Check Out Our Latest Research Report on CNC
Insiders Place Their Bets
In other Centene news, General Counsel Christopher Koster sold 56,500 shares of the business’s stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $66.90, for a total value of $3,779,850.00. Following the sale, the general counsel directly owned 248,854 shares in the company, valued at $16,648,332.60. The trade was a 18.50% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.37% of the company’s stock.
Centene Price Performance
Shares of NYSE CNC opened at $67.64 on Thursday. Centene Corporation has a twelve month low of $31.63 and a twelve month high of $78.08. The stock’s 50 day moving average price is $67.45 and its 200-day moving average price is $56.94. The company has a market capitalization of $33.49 billion, a PE ratio of 23.17, a PEG ratio of 0.42 and a beta of 1.07. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.69.
Centene (NYSE:CNC – Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.48. The company had revenue of $50.65 billion during the quarter, compared to analyst estimates of $47.12 billion. Centene had a return on equity of 12.15% and a net margin of 0.72%. Centene’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.50 earnings per share. On average, equities analysts anticipate that Centene Corporation will post 5.27 EPS for the current year.
Centene Company Profile
Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.
Further Reading
- Five stocks we like better than Centene
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
